Increment of efficiency in the identification of noble genes by colony hybridization assay (screening of low redundant clones from human fetal cDNA library)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, J.W. | - |
dc.contributor.author | Lee, I.A. | - |
dc.contributor.author | Lee, Y.H. | - |
dc.contributor.author | Song, J.C. | - |
dc.contributor.author | Choe, Y.K. | - |
dc.contributor.author | Hahn, Yoon Soo | - |
dc.contributor.author | Chung, J.H. | - |
dc.contributor.author | Chung, T.W. | - |
dc.contributor.author | Choe, I.S. | - |
dc.date.accessioned | 2022-05-13T01:40:27Z | - |
dc.date.available | 2022-05-13T01:40:27Z | - |
dc.date.issued | 1998-02 | - |
dc.identifier.issn | 1039-9712 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/57596 | - |
dc.description.abstract | For the rapid identification of noble genes in a specific tissue by computer analysis from the cDNA sequences determined by single-pass cDNA sequencing, clone redundancy was one of the major obstacles. To facilitate the efficiency in identification of noble genes, it was necessary to reduce the number of clones to be sequenced by eliminating the redundant clones for a rapid analysis. In order to increase the probability of isolating noble sequences from the cDNA clones of human fetal liver tissue origin, colony hybridization assay was adopted and redundant clones were efficiently removed. Four cDNA clones highly redundant in the human fetal liver cDNA libraries including alpha-globin, gamma-globin, serum albumin and H19 RNA sequences were selected as the probes. Two hundreds and sixty two cDNA clones were randomly selected and tested with the probes for hybridization properties. The identity of each cDNA clone giving positive or negative signals in the hybridization assay was determined by DNA homology search with the nucleic acid databases. Among the 76 clones giving positive signals, 57 clones (75%) were found to be identical to the probe sequences and could be eliminated by colony hybridization assay before neucleotide sequencing. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ACADEMIC PRESS AUST | - |
dc.title | Increment of efficiency in the identification of noble genes by colony hybridization assay (screening of low redundant clones from human fetal cDNA library) | - |
dc.type | Article | - |
dc.identifier.doi | 10.1080/15216549800201252 | - |
dc.identifier.bibliographicCitation | BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL, v.44, no.2, pp 225 - 233 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 000072404900002 | - |
dc.identifier.scopusid | 2-s2.0-0031911898 | - |
dc.citation.endPage | 233 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 225 | - |
dc.citation.title | BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL | - |
dc.citation.volume | 44 | - |
dc.type.docType | Article | - |
dc.publisher.location | 호주 | - |
dc.subject.keywordAuthor | human fetal liver cDNA | - |
dc.subject.keywordAuthor | redundancy | - |
dc.subject.keywordAuthor | prescreening | - |
dc.subject.keywordAuthor | hybridization assay | - |
dc.subject.keywordPlus | EXPRESSED SEQUENCE TAGS | - |
dc.subject.keywordPlus | CONSTRUCTION | - |
dc.subject.keywordPlus | SUBTRACTION | - |
dc.subject.keywordPlus | SYSTEM | - |
dc.subject.keywordPlus | LIVER | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.